<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01135719</url>
  </required_header>
  <id_info>
    <org_study_id>SU-04302009-2458</org_study_id>
    <nct_id>NCT01135719</nct_id>
  </id_info>
  <brief_title>A Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser</brief_title>
  <official_title>A Prospective Randomized Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edward E. Manche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subjects with myopia, hyperopia and astigmatism are being randomized to be treated in one eye
      with a wavefront-guided excimer laser and their fellow eye treated with a wavefront-optimized
      excimer laser.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects with myopia, hyperopia and astigmatism are being randomized by ocular dominance to
      be treated with either PRK or LASIK. One eye will be treated with a wavefront-guided excimer
      laser and the fellow eye will be treated with a wavefront optimized excimer laser.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in best spectacle corrected visual acuity.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in 25 and 5% low contrast visual acuity.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in uncorrected visual acuity</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in higher order aberrations.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Topographic changes.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of vision changes.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hyperopia</condition>
  <condition>Myopia</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Wavefront guided LASIK/PRK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wavefront-guided LASIK/PRK</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wavefront optimized LASIK/PRK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wavefornt optimized LASIK/PRK</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LASIK and PRK</intervention_name>
    <description>Wavefront-guided versus wavefront-optimized LASIK or PRK.</description>
    <arm_group_label>Wavefront guided LASIK/PRK</arm_group_label>
    <arm_group_label>Wavefront optimized LASIK/PRK</arm_group_label>
    <other_name>Allegretto Wave Eye-Q 400 Hz excimer laser</other_name>
    <other_name>Visx CustomVue excimer laser</other_name>
    <other_name>Laser in-situ keratomileusis</other_name>
    <other_name>Photorefractive keratectomy</other_name>
    <other_name>Wavefront-guided</other_name>
    <other_name>Wavefront-optimized</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects age 21 and older.

          -  Subjects with nearsightedness, farsightedness and/or astigmatism.

        Exclusion Criteria:Autoimmune diseases.

          -  Children.

          -  Women pregnant or nursing.

          -  Ectatic corneal disease.

          -  Previous ocular surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward E. Manche</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2009</study_first_submitted>
  <study_first_submitted_qc>June 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2010</study_first_posted>
  <last_update_submitted>April 22, 2018</last_update_submitted>
  <last_update_submitted_qc>April 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Edward E. Manche</investigator_full_name>
    <investigator_title>Stanford University School of Medicine</investigator_title>
  </responsible_party>
  <keyword>Myopia</keyword>
  <keyword>Hyperopia</keyword>
  <keyword>Astigmatism</keyword>
  <keyword>PRK</keyword>
  <keyword>LASIK</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Hyperopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

